Development of a Novel Canine Parvovirus Vaccine Capable of Stimulating Protective Immunity in Four-Week-Old Puppies in the Face of High Levels of Maternal Antibodies

Many highly effective vaccines have been developed to protect dogs against disease caused by canine parvovirus, but despite this vaccine interference by maternally derived antibodies continues to cause immunisation failure. To help overcome this limitation we have developed a novel, recombinant cani...

Descripción completa

Detalles Bibliográficos
Autores principales: Pearce, Jacqueline, Spibey, Norman, Sutton, David, Tarpey, Ian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10534519/
https://www.ncbi.nlm.nih.gov/pubmed/37766175
http://dx.doi.org/10.3390/vaccines11091499

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10534519/
https://www.ncbi.nlm.nih.gov/pubmed/37766175
http://dx.doi.org/10.3390/vaccines11091499

Ejemplares similares